BUPIVACAINE HYDROCHLORIDE IN DEXTROSE INJECTION USP
FORMATIVE PHARMA INC.
View this drug's full profile page →
This is a national manufacturer shortage report. It does not confirm whether the product is unavailable at your local pharmacy — call ahead or ask your pharmacist.
Quick answers
Is there a shortage of BUPIVACAINE HYDROCHLORIDE IN DEXTROSE INJECTION USP in Canada?
A shortage of BUPIVACAINE HYDROCHLORIDE IN DEXTROSE INJECTION USP 7.5MG is expected: the manufacturer reported it to Health Canada as an anticipated shortage (last updated September 21, 2026), but it has not started yet.
Why is BUPIVACAINE HYDROCHLORIDE IN DEXTROSE INJECTION USP not available?
The reason the manufacturer reported: Requirements related to complying with good manufacturing practices.
When will BUPIVACAINE HYDROCHLORIDE IN DEXTROSE INJECTION USP be available again?
No estimated resolution date has been reported yet. Follow this page to get an email as soon as the status changes.
Other Products Containing the Same Active Ingredient
These are other Health Canada-approved human drug products containing the same active ingredient, not currently reported in shortage. Strength, dosage form, and route can still differ — ask your pharmacist whether any of these are appropriate for you. This isn't a guarantee of current stock.
Other Products
BUPIVACAINE HYDROCHLORIDE INJECTION USP .75%
HOSPIRA HEALTHCARE ULC
MARCAINE 0.75% LIQ SPINAL 7.5MG/ML
SANOFI CANADA, INC.
MARCAINE 0.75% LIQ PRT 7.5MG/ML
SANOFI CANADA, INC.
SENSORCAINE
ASPEN PHARMACARE CANADA INC.
BUPIVACAINE HYDROCHLORIDE INJECTION USP .50%
HOSPIRA HEALTHCARE ULC
BUPIVACAINE HYDROCHLORIDE INJECTION USP .25%
HOSPIRA HEALTHCARE ULC
What this means
Does this mean my pharmacy is already out of stock?
No — this shortage hasn't started yet. It's an early warning that supply may become tight, based on information from the manufacturer.
What should I do?
No action is needed yet. It's worth asking your pharmacist at your next refill whether they expect any disruption for this product.
DIN
02536714
Strength
7.5MG
Dosage Form
SOLUTION
Route
INTRASPINAL
Active Ingredient
BUPIVACAINE HYDROCHLORIDE
Tier
Tier 3 — Critical
Last Updated
2026-09-21
Reason for Shortage
Requirements related to complying with good manufacturing practices.
Other Products from FORMATIVE PHARMA INC.
Other Health Canada-approved products made by the same manufacturer — not necessarily related to this shortage, and not necessarily in shortage themselves.
250MG · DIN 02539586
45MG · DIN 02553783
60MG · DIN 02553791
250MG · DIN 02536293
500MG · DIN 02537168
10MG · DIN 02534827
20MG · DIN 02547856